HIV-1 drug-resistance and drug-dependence
2007

HIV-1 Drug Resistance and Dependence

Sample size: 17 publication Evidence: moderate

Author Information

Author(s): Chris Baldwin, Ben Berkhout

Primary Institution: Academic Medical Center of the University of Amsterdam

Hypothesis

The evolution of drug-dependence in HIV-1 variants occurs through the selection of drug-resistance mutations followed by compensatory mutations that enhance viral fitness in the presence of the drug.

Conclusion

Drug-dependent HIV-1 variants can emerge during therapy, which may complicate treatment and require modifications to drug regimens.

Supporting Evidence

  • Drug-dependent HIV-1 variants can emerge during antiviral therapy.
  • The evolution of drug-dependence often involves initial drug-resistance mutations followed by compensatory mutations.
  • Drug-dependent variants may not replicate without the drug, complicating treatment strategies.

Takeaway

Some HIV viruses can become dependent on a drug to survive, meaning they can't replicate without it, which can make treating the infection tricky.

Methodology

The review discusses various studies on HIV-1 variants selected for drug-dependence and resistance mutations.

Limitations

The review may not cover all possible drug-dependent variants and their clinical implications.

Participant Demographics

The review references studies involving patients undergoing T20 therapy.

Digital Object Identifier (DOI)

10.1186/1742-4690-4-78

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication